Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke

Abstract

Background and Purpose-The National Institutes of Health (NIH) estimates that stroke costs now exceed $45 billion per year.Stroke is the third leading cause of death and one of the leading causes of adult disability in North America, Europe, and Asia. A number of well-designed randomized stroke trials and case series have now been reported in the literature to evaluate the safety and efficacy of thrombolytic therapy for the treatment of acute ischemic stroke. These stroke trials have included intravenous studies, intra-arterial studies, and combinations of both, as well as use of mechanical devices for removal of thromboemboli and of neuroprotectant drugs, alone or in combination with thrombolytic therapy. At this time, the only therapy demonstrated to improve outcomes from an acute stroke is thrombolysis of the clot responsible for the ischemic event.There is room for improvement in stroke lysis studies. Divergent criteria, with disparate reporting standards and definitions, have made direct comparisons between stroke trials difficult to compare and contrast in terms of overall patient outcomes and efficacy of treatment. There is a need for more uniform definitions of multiple variables such as collateral flow, degree of recanalization, assessment of perfusion, and infarct size.In addition, there are multiple unanswered questions that require further investigation, in particular, questions as to which patients are best treated with thrombolysis. One of the most important predictors of clinical success is time to treatment, with early treatment of Ͻ3 hours for intravenous tissue plasminogen activator and Ͻ6 hours for intra-arterial thrombolysis demonstrating significant improvement in terms of 90-day clinical outcome and reduced cerebral hemorrhage. It is possible that improved imaging that identifies the ischemic penumbra and distinguishes it from irreversibly infarcted tissue will more accurately select patients for therapy than duration of symptoms. There are additional problems in the assessment of patients eligible for thrombolysis. These include being able to predict whether a particular site of occlusion can be successfully revascularized, predict an individual patient's prognosis and outcome after revascularization, and in particular, to predict the development of intracerebral hemorrhage, with and without clinical deterioration. It is not clear to assume that achieving immediate flow restoration due to thrombolytic therapy implies clinical success and improved outcome. There is no simple correlation between recanalization and observed clinical benefit in all ischemic stroke patients, because other interactive variables, such as collateral circulation, the ischemic penumbra, lesion location and extent, time to treatment, and hemorrhagic conversion, are all interrelated to outcome. Methods-This article was written under the auspices of the Technology Assessment Committees for both the AmericanSociety of Interventional and Therapeutic Neuroradiology and the Society of Interventional Radiology. The purpose ...

Collateral state and the effect of endovascular reperfusion therapy on clinical outcome in ischemic stroke patients

“…In contrast to DSA (Higashida et al. 2003), no generally accepted grading system exists so far for the assessment of collaterals on CTA (McVerry et al. 2012).…”

Cost benefits of rapid recanalization using intraarterial thrombectomy

“…Stroke severity and clinical improvement were assessed based on NIHSS score immediately after ER arrival, and immediately, 24‐hr, and 3‐days post‐IAT, and at discharge after acute stroke management. The symptom onset‐to‐recanalization time was calculated as the time from symptom onset to successful recanalization (defined as thrombolysis in cerebral infarction grade 2b/3) (Roth et al., 2010) post‐IAT (Higashida et al., 2003). Symptomatic intracerebral hemorrhage (ICH) was defined as a large hematoma associated with a ≥ 4‐point increase in NIHSS score within 24 hr post‐IAT (Khatri, Wechsler, & Broderick, 2007).…”

Alberta Stroke Program Early CT Score applied to CT angiography source images is a strong predictor of futile recanalization in acute ischemic stroke

“…Vessel occlusion or recanalizationwas defined according to the thrombolysis in brain ischemia (TIBI) grading system [12], using transcranial ultrasound assessment, and according to the thrombolysis in cerebral infarction (TICI) grading system in angiography [13]. Successful recanalization was considered as TIBI 4 or 5 and TICI 2b or 3.…”